• Phone
  • Contact us
  • Locations
  • Search
  • Menu


  • Add this article to your LinkedIn page
  • Add this article to your Twitter feed
  • Email this article
View or print a PDF of this page
Strategies for commercial excellence

Creating and implementing strategies for commercial excellence


PA Consulting Group's broad and deep commercial experience of the pharmaceutical and biotech sectors enables clients to maximise value from their products and services. We help them increase and prolong revenues, and quicken their time to profit by aggressively managing related costs.

Throughout the life cycle of their commercial assets – from discovery through development and commercialisation to late-life-cycle management – we offer many strategies to achieve their goals.

We delivered a new standard change management approach for ICON

Market assessment and commercial strategy

We combine deep sector knowledge with a proven approach to define the future scenarios our clients will be operating in. From this solid foundation we can build the requirements for business success in their markets. We provide direction on prioritising and leveraging existing assets to maximise their value, and how to fill conspicuous gaps.

We developed an innovative technology strategy for a US sales force.

Product and portfolio management through the life cycle

PA provides strategic advice and recommendations on the management of  assets, individually or in the context of the overall portfolio. We have extensive experience of value management in the pharmaceutical and biotech sectors across the commercial life cycle of the assets, and across the portfolio.

From discussions with the client PA identifies the product and portfolio strategy which is the best fit and value-adding today, and in the future. Our tools and techniques provide a robust approach to address the key issues of governance, infrastructure, process, people, and data.

We developed and implemented portfolio modelling to support new product development for Norton Healthcare.

Delivering excellence in commercial operations

Effective market access for products and services is essential to the pharmaceutical and biotech sectors. Several factors are essential to attain that goal, developing the products and services that the markets need, setting the right price to secure reimbursement and market uptake, presenting a proposition that is aligned with market expectations, and effective communication of the products' differentiation.

We delivered a comprehensive database of drug prices in Europe

Additionally market evolution has created new customer communities  - clinical and non-clinical - which provide new challenges for the industry.

PA's rapidly creates experienced teams which engage with clients' challenges to deliver the strategic review, diagnosis, and solutions required to maximise value from commercial operations.

Our sector experience includes market awareness, commercial goals and issues, strategy, sales operations, and information management with IT strategy and infrastructure.

To discuss an issue on commercial strategy or operations, please contact us now.

Andrew Hooke
Life sciences
contact us now

By using this website, you accept the use of cookies. For more information on how to manage cookies, please read our privacy policy.